Page last updated: 2024-08-24

sulofenur and Cancer of Ovary

sulofenur has been researched along with Cancer of Ovary in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	3 (75.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (25.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Jung, SH; Kang, JS; Kim, HM; Kim, NS; Lee, KC; Sharma, VK; Subramanian, S; Thanigaimalai, P	1
Alberts, DS; Grindey, GB; Hamilton, M; Matzner, M; McCloskey, TM; Peng, YM; Plezia, PM; Roe, DJ; Seitz, D; Taylor, CW	1
Hardy, J; Hatty, S; O'Brien, ME; Peters, B; Tan, S; Walling, J; Wiltshaw, E	1
Alberts, DS; Fossella, FV; Hardy, J; Haynes, TR; Lippman, SM; O'Brien, M; Seitz, DE; Taylor, CW; Wiltshaw, E; Wolen, RL	1

Trials

3 trial(s) available for sulofenur and Cancer of Ovary

Article	Year
Antitumor activity and clinical pharmacology of sulofenur in ovarian cancer. Journal of the National Cancer Institute, 1992, Dec-02, Volume: 84, Issue:23 Topics: Adult; Aged; Aged, 80 and over; Anemia; Antineoplastic Agents; Carcinoma; Drug Administration Schedule; Female; Humans; Methemoglobinemia; Middle Aged; Ovarian Neoplasms; Sulfonylurea Compounds	1992
A phase II study of sulofenur, a novel sulfonylurea, in recurrent epithelial ovarian cancer. Cancer chemotherapy and pharmacology, 1992, Volume: 30, Issue:3 Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Carcinoma; Cisplatin; Drug Evaluation; Drug Resistance; Female; Humans; Middle Aged; Ovarian Neoplasms; Recurrence; Sulfonylurea Compounds	1992
Hypoprothrombinemia from coadministration of sulofenur (LY 186641) and warfarin: report of three cases. Investigational new drugs, 1991, Volume: 9, Issue:4 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Drug Evaluation; Drug Interactions; Female; Humans; Hypoprothrombinemias; Lung Neoplasms; Middle Aged; Ovarian Neoplasms; Sulfonylurea Compounds; Warfarin	1991

Other Studies

1 other study(ies) available for sulofenur and Cancer of Ovary

Article	Year
Structure--activity relationship studies of novel arylsulfonylimidazolidinones for their anticancer activity. European journal of medicinal chemistry, 2011, Volume: 46, Issue:8 Topics: Animals; Antineoplastic Agents; Arylsulfonates; Cell Line, Tumor; Cell Survival; Colonic Neoplasms; Doxorubicin; Drug Screening Assays, Antitumor; Female; Humans; Hydrophobic and Hydrophilic Interactions; Imidazolidines; Lung Neoplasms; Mice; Mice, Nude; Molecular Conformation; Neoplasm Transplantation; Ovarian Neoplasms; Structure-Activity Relationship	2011

Article

Year

Structure--activity relationship studies of novel arylsulfonylimidazolidinones for their anticancer activity.

European journal of medicinal chemistry, 2011, Volume: 46, Issue:8

Topics: Animals; Antineoplastic Agents; Arylsulfonates; Cell Line, Tumor; Cell Survival; Colonic Neoplasms; Doxorubicin; Drug Screening Assays, Antitumor; Female; Humans; Hydrophobic and Hydrophilic Interactions; Imidazolidines; Lung Neoplasms; Mice; Mice, Nude; Molecular Conformation; Neoplasm Transplantation; Ovarian Neoplasms; Structure-Activity Relationship

2011